Viewing Study NCT00486460

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-02 @ 6:23 PM
Study NCT ID: NCT00486460
Status: UNKNOWN
Last Update Posted: 2007-06-14
First Post: 2007-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally advanced or metastatic adenocarcinoma of the View
None pancreas View
None confirmed by histology or cytology View
None Inoperatable View